These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9624234)

  • 41. Anti-cancer effects of Ajwa dates (Phoenix dactylifera L.) in diethylnitrosamine induced hepatocellular carcinoma in Wistar rats.
    Khan F; Khan TJ; Kalamegam G; Pushparaj PN; Chaudhary A; Abuzenadah A; Kumosani T; Barbour E; Al-Qahtani M
    BMC Complement Altern Med; 2017 Aug; 17(1):418. PubMed ID: 28830415
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Re: Liu et al.--Estrogen receptor status in inoperable hepatocellular carcinoma.
    Chow PK; Hung H; Soo KC
    Am J Gastroenterol; 2001 Apr; 96(4):1297-8. PubMed ID: 11316190
    [No Abstract]   [Full Text] [Related]  

  • 43. Extending the clinical benefit of endocrine therapy for women with hormone receptor-positive metastatic breast cancer: differentiating mechanisms of action.
    Glück S
    Clin Breast Cancer; 2014 Apr; 14(2):75-84. PubMed ID: 24355138
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Steroid sex hormones and prolactin in postmenopausal women with generalized mammary carcinoma during prolonged dexamethasone treatment.
    Borkowski A; L'hermite M; Dor P; Longeval E; Rozencweig M; Muquardt C; Van Cauter E
    J Endocrinol; 1977 May; 73(2):235-46. PubMed ID: 140915
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Megestrol treatment in patients with hepatocellular carcinoma.
    Farinati F; Gianni S; De Giorgio M; Fiorentini S
    Br J Cancer; 2001 Nov; 85(10):1606-8. PubMed ID: 11720452
    [No Abstract]   [Full Text] [Related]  

  • 46. Randomized controlled trial of tamoxifen in advanced hepatocellular carcinoma.
    Barbare JC; Bouché O; Bonnetain F; Raoul JL; Rougier P; Abergel A; Boige V; Denis B; Blanchi A; Pariente A; Milan C; Bedenne L
    J Clin Oncol; 2005 Jul; 23(19):4338-46. PubMed ID: 15994145
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of acyclic retinoid in the chemoprevention of hepatocellular carcinoma: basic aspects, clinical applications, and future prospects.
    Shimizu M; Imai K; Takai K; Moriwaki H
    Curr Cancer Drug Targets; 2012 Nov; 12(9):1119-28. PubMed ID: 22873214
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mechanisms and influence of octreotide-induced regulation of somatostatin receptor 2 on hepatocellular carcinoma.
    Hua YP; Yin XY; Peng BG; Li SQ; Lai JM; Liang HZ; Liang LJ
    Chemotherapy; 2009; 55(5):312-20. PubMed ID: 19590186
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular mechanisms of endocrine resistance and their implication in the therapy of breast cancer.
    Zilli M; Grassadonia A; Tinari N; Di Giacobbe A; Gildetti S; Giampietro J; Natoli C; Iacobelli S;
    Biochim Biophys Acta; 2009 Jan; 1795(1):62-81. PubMed ID: 18804516
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fibrolamellar variant of hepatocellular carcinoma does not have a better survival than conventional hepatocellular carcinoma--results and treatment recommendations from the Childhood Liver Tumour Strategy Group (SIOPEL) experience.
    Weeda VB; Murawski M; McCabe AJ; Maibach R; Brugières L; Roebuck D; Fabre M; Zimmermann A; Otte JB; Sullivan M; Perilongo G; Childs M; Brock P; Zsíros J; Plaschkes J; Czauderna P; Aronson DC
    Eur J Cancer; 2013 Aug; 49(12):2698-704. PubMed ID: 23683550
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women.
    Gibson LJ; Dawson C; Lawrence DH; Bliss JM
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003370. PubMed ID: 17253488
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.
    Viale G; Regan MM; Maiorano E; Mastropasqua MG; Golouh R; Perin T; Brown RW; Kovács A; Pillay K; Ohlschlegel C; Braye S; Grigolato P; Rusca T; Gelber RD; Castiglione-Gertsch M; Price KN; Goldhirsch A; Gusterson BA; Coates AS
    J Clin Oncol; 2008 Mar; 26(9):1404-10. PubMed ID: 18349391
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vivo models for endocrine-dependent breast carcinomas: special considerations of clinical relevance.
    Fichtner I; Becker M; Zeisig R; Sommer A
    Eur J Cancer; 2004 Apr; 40(6):845-51. PubMed ID: 15120040
    [TBL] [Abstract][Full Text] [Related]  

  • 54. EFFECTS OF SEX HORMONES ON THE EXCRETION OF BLASTOMOGENIC AZO-DYE IN MICE.
    BELITSKY GA
    Acta Unio Int Contra Cancrum; 1963; 19():769-70. PubMed ID: 14050663
    [No Abstract]   [Full Text] [Related]  

  • 55. Vascular endothelial growth factor monitoring in advanced hepatocellular carcinoma patients treated with radiofrequency ablation plus octreotide: a single center experience.
    Montella L; Addeo R; Caraglia M; Faiola V; Guarrasi R; Vincenzi B; Palmeri A; Capasso E; Nocera V; Tarantino L; Ariete M; Martorelli A; Del Prete S
    Oncol Rep; 2008 Aug; 20(2):385-90. PubMed ID: 18636202
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cytochrome P450 1A2 Metabolizes 17β-Estradiol to Suppress Hepatocellular Carcinoma.
    Ren J; Chen GG; Liu Y; Su X; Hu B; Leung BC; Wang Y; Ho RL; Yang S; Lu G; Lee CG; Lai PB
    PLoS One; 2016; 11(4):e0153863. PubMed ID: 27093553
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Experimental studies on endocrine therapy for rat hepatocellular carcinoma].
    Zeze F; Onami S; Osato K
    Nihon Geka Gakkai Zasshi; 1995 Nov; 96(11):760-5. PubMed ID: 8569676
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sex hormone imbalance in male alcoholic cirrhotic patients with and without hepatocellular carcinoma.
    Guéchot J; Peigney N; Ballet F; Vaubourdolle M; Giboudeau J; Poupon R
    Cancer; 1988 Aug; 62(4):760-2. PubMed ID: 2840190
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Study of urinary steroid hormone disorders: difference between hepatocellular carcinoma in early stage and cirrhosis.
    Dai W; Yin P; Chen P; Kong H; Luo P; Xu Z; Lu X; Xu G
    Anal Bioanal Chem; 2014 Jul; 406(18):4325-35. PubMed ID: 24817358
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Proceedings of the Fifth International Conference on Recent Advances and Future Directions in Endocrine Therapy for Breast Cancer: conference summary statement.
    Come SE; Buzdar AU; Ingle JN; Arteaga CL; Brown M; Dowsett M; Hilsenbeck SG; Kumar R; Johnston SR; Lee AV; Paik S; Pritchard KI; Winer EP; Hart C
    Clin Cancer Res; 2006 Feb; 12(3 Pt 2):997s-1000s. PubMed ID: 16467115
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.